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In addition to original articles, the Journal of Oral Biosciences
publishes review articles by winners of the ‘‘Lion Dental Research
Award’’ and ‘‘Rising Members Award’’ presented by the Japanese
Association for Oral Biology as well as reviews of recent informa-
tion presented by the speakers at a symposium held during the
annual meeting of the Association. In 2012, we published special
issues featuring reviews on the following topics: ‘‘Microbial
pathogenesis and research strategies to address oral and related
infectious diseases,’’ ‘‘How does the human brain drive orofacial
function?,’’ ‘‘Role of extracellular matrices in the regulation of
mineralized tissue,’’ ‘‘Studies on membrane trafﬁc in the dental
sciences,’’ ‘‘Leading edge of oral bioﬁlm research—challenges in
the correct understanding of oral disease caused by bioﬁlm,’’
‘‘From oral sciences to health sciences—promotion of oral health
sciences,’’ ‘‘Studies in infection and immunity by the upcoming
generation,’’ ‘‘Challenges for new horizons in bone research,’’ and
‘‘Dynamism of the extracellular environment.’’ These reviews in
the Journal of Oral Biosciences will inspire our readers to widen
their knowledge of various aspects of oral biosciences. The
current editorial review introduces the following exciting studies.2. Microbial pathogenesis and research strategies to address
oral and related infectious diseases
Staphylococcus aureus is a major pathogenic bacterium that
causes various diseases in humans [1,2]. In the ﬁeld of dentistry,
S. aureus is known to cause osteomyelitis, pericoronitis, and radi-
cular cysts as an opportunistic pathogen and has become a clinically
signiﬁcant problem as a major pathogen involved in nosocomial
infections. Since the emergence of methicillin-resistant S. aureus
(MRSA), many researchers have studied the antibiotic resistance of
MRSA, especially resistance to b-lactam antibiotics and vancomycin.
Kawada–Matuo and Komatsuzawa reviewed the current research on
b-lactam and vancomycin resistance with an emphasis on their own
studies and introduced the mechanism of S. aureus resistance to
antimicrobial peptides [3]. Although many studies have been con-
ducted to elucidate the mechanisms of resistance to methicillin and
vancomycin through identiﬁcation of the factors affecting suscept-
ibility to b-lactams, the authors recently demonstrated that MRSA
shows resistance to endogenous antimicrobial peptides that are
components of the human innate immune system as well as to
various antibiotics [4,5]. Tuberculosis (TB) is an infectious disease for
which the only available vaccine is bacillus Calmette–Guerin (BCG).
Ohara introduced a recent research strategy for the development of
a novel vaccine against TB [6]. Many other researchers have focused79/$ - see front matter & 2013 Japanese Association for Oral Biology. Published
x.doi.org/10.1016/j.job.2013.01.002on developing BCG into a novel vaccine vehicle that is capable of
simultaneously expressing recombinant antigens from multiple
pathogens [7]. There is now a new stable and clinically available
antibiotic-free host-vector system that expresses the foreign anti-
gens from BCG. Streptococcus pyogenes possesses a wild variety of
virulence factors and can cause severe invasive infections [8]. Terao
and his colleagues identiﬁed 2 novel ﬁbronectin-binding proteins
(FbaA and FbaB) in S. pyogenes isolates from patients with severe
invasive infections [9,10] and suggested that Fba proteins are
virulence factors responsible for the development of severe invasive
S. pyogenes infections. Furthermore, they identiﬁed a C6-binding
protein in cell-surface protein fractions from S. pyogenes. Terao
provided the recent knowledge that S. pyogenes is equipped with a
wide variety of virulence factors for invading human tissue and
evading the immune response [11].3. How does the human brain drive orofacial function?
In dentistry, conditions characterized by exaggerated oromo-
tor activities during sleep, such as sleep bruxism (SB), have been
thought to stem from orodental morphological factors such as
occlusion. Conversely, recent studies have revealed that the
genesis of SB is linked to sleep physiology. Kato and his colleagues
reviewed the physiological association between cortical and
oromotor activities during sleep in order to understand jaw motor
activities during sleep [12]. During sleep, jaw motor activities
occur in association with transient changes in cortical EEG
activity related to sleep regulatory functions [13]. Patients with
psychosis commonly have deﬁcits in social interaction. Kato and
Mimura reviewed various aspects of the social deﬁcits affecting
patients with psychosis in relation to dysfunction of the mirror
neuron system (MNS), the possible neural basis of social interac-
tion [14]. The deﬁciencies in social interaction exhibited by
patients with psychosis are thought to stem from changes in
the ‘‘theory of mind’’ (ToM). The MNS is speculated to be the
neural substrate of the ToM, and dysfunction of this system could
give rise to the social problems experienced by many patients
[14]. In the somatosensory system, sensory stimuli applied to the
orofacial area are received by sensory receptors. These sensory
signals are projected to the primary and secondary somatosen-
sory cortices, which are necessary for the perception of oral
sensation. Shibukawa described cortical function as it relates to
orofacial somatosensory function [15]. Functional magnetic reso-
nance imaging (fMRI) has considerably advanced the understand-
ing of the peripheral and central neural mechanisms underlying
orofacial movements such as chewing, swallowing, digestion, and
speech. Sahara and his colleagues reviewed the available evidenceby Elsevier B.V. All rights reserved.
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fMRI methods [16].4. Role of extracellular matrices in the regulation of
mineralized tissue
Bone is a hard tissue that shapes, supports, and protects the
human body. The bone also aids body movement, houses bone
marrow, and stores various minerals essential for homeostasis.
These functions depend on its calciﬁcation. Hoshi overviewed the
morphological ﬁndings on bone calciﬁcation and discussed the
mineral and organic environments in calcifying bone matrix [17]
based on his previous studies [18–20]. The structural and posi-
tional changes of various organic substances in the bone matrix are
deeply involved in bone calciﬁcation. Matrix metalloproteinases
(MMPs) play a central role in the breakdown of extracellular
matrices (ECM); this breakdown is essential for embryonic devel-
opment, morphogenesis, and tissue remodeling [21,22]. Sasano
and his colleagues reviewed their recent studies [23,24] and
relevant previous reports on the expression of enzymes such as
matrix metalloproteinases in the development of bones and teeth
as well as bone healing [25]. Osteoblasts, osteocytes, odontoblasts,
cementoblasts, cementocytes, and ameloblasts express MMPs
during these processes and may remodel ECM proteins in their
speciﬁc matrices and thus initiate and advance calciﬁcation. Dentin
matrix protein 1 (DMP1) is a member of the SIBLING (small
integrin-binding ligand, N-linked glycoprotein) family of geneti-
cally related noncollagenous proteins found in mineralized tissues
[26]. Toyosawa and his colleagues introduced the current knowl-
edge of DMP1 in bone formation and homeostasis [27]. DMP1 was
originally postulated to be dentin-speciﬁc but was later found to be
expressed predominantly in bone osteocytes [28]. Both DMP1-null
mice and humans with mutations in DMP1 causing autosomal-
recessive hypophosphatemic rickets (ARHR) exhibit elevated
serum levels of ﬁbroblast growth factor 23 (FGF23); this increases
renal phosphate wasting, leading to hypophosphatemia [29–32].
These ﬁndings indicate that regulation of matrix mineralization by
DMP1 is coupled with renal phosphate homeostasis through the
production of FGF23 by osteocytes. Osteocytes form up functional
syncytia, i.e., the osteocytic lacunar-canalicular system (OLCS) [33].
Amizuka and his colleagues introduced their recent studies [34,35]
on the regularity of the OLCS and the synthesis of osteocyte-
derived FGF23 and sclerostin [33]. The geometrically regular OLCS
is a functional syncytium in which FGF23 and sclerostin are
expressed. The regularity of the OLCS seems to be established by
the physiological bone remodeling required for bone maturation.
Bone matrix consists of hydroxyapatite and organic components
such as type I collagen and non-collagenous proteins. Heparan
sulfate proteoglycans (HSPGs) exist in extracellular matrix and/or
membrane-bound forms, both of which are localized to the
intercellular spaces of osteoblast-lineage cells. Nakamura and his
colleagues focused on the possible roles of HSPGs in the differ-
entiation of bone cells in their review paper [36]. Heparan sulfate
(HS) chains could bind heparin-binding proteins, including ﬁbro-
nectin, and several growth factors, such as bone morphogenetic
proteins, via their highly negative charges. HSPGs in bone tissue
may help to establish the microenvironment necessary for the
differentiation of osteoblasts, osteoclasts, and hematopoietic cells
[37,38].5. Studies on membrane trafﬁc in the dental sciences
Cathepsin E is an intracellular aspartic proteinase of the pepsin
super family that is predominantly expressed in certain cell types,such as immune-related cells and rapidly regenerating cells [39].
Tsukuba and his colleagues discussed the molecular mechanisms
of the regulation of membrane trafﬁcking by cathepsin E in
antigen-presenting cells (APC) such as macrophages, dendritic
cells, and microglia [40]. Abnormal membrane trafﬁcking prob-
ably leads to aberrant cellular function and thereby further
disrupts host defense mechanisms. Indeed, the authors recently
found that cathepsin E deﬁciency induces abnormal endocytic,
autophagic, and secretory events and interferes with the matura-
tion and fusion of macrophage organelles, thereby impairing the
structural and functional integrity of these cells [41,42]. Gingival
epithelial cells function as an innate host defense system
to prevent the intrusion of periodontal bacteria. Nevertheless,
Porphyromonas gingivalis, the most well-known periodontal
pathogen, can enter gingival epithelial cells and pass through
the epithelial barrier into deeper tissues [43]. Amano and Furuta
addressed the remarkable strategies used by P. gingivalis to invade
and exit from periodontal cells [42]. Efﬁcient bacterial entry into
gingival cells is considered to be tightly related to the cytotoxicity
of periodontal pathogens. Recent studies have found that human
oral epithelial cells harbor large intracellular masses of bacterial
consortia with characteristics reminiscent of the polymicrobial
nature of tooth-surface bioﬁlm [43,44]. The intracellular fate of
each bacterium may be determined by the cellular membrane
trafﬁcking of intracellular pathogens [45].6. Leading edge of oral bioﬁlm research—Challenges in the
correct understanding of oral disease caused by bioﬁlm
In recent years, genetic techniques have been applied to the
analysis of the constitutive bacterial species of the oral microbiota.
Universal PCR ampliﬁcation using primers targeting the same
conserved area of 16S rRNA is commonly used to analyze a wide
variety of bacterial species simultaneously [46]. Many reports in
which 16S rRNA gene ampliﬁcation was the ﬁrst step are inher-
ently biased towards analyzing only the predominant organisms.
Kawamura and Kamiya introduced a new technique, ‘‘DNA deduc-
tion,’’ that allows us to determine the diversity of the bacterial ﬂora
of the mouth, including minor species that may previously have
been overlooked [47]. Consequently, they concluded that the DNA
deduction technique will lead to a better understanding of the
diversity of the human oral microbiota [48]. Research approaches
to bioﬁlm are stratiﬁed by a series of analyses: (1) microbial
number and species; (2) microbial proteins, such as enzymes;
and (3) microbial activity, such as metabolic activity [49]. Takaha-
shi and his colleagues introduced a new research approach to oral
bioﬁlm [50]. Metabolome analysis is a powerful tool for probing
the metabolic characteristics of the entire oral bioﬁlm and may
provide new insights into the nature of the oral bioﬁlm in health
and disease [51]. Furthermore, metabolome analysis may enable us
not only to characterize the metabolic properties of oral bioﬁlm
in vivo but also to elucidate the in vivo efﬁcacies of drugs, from
classical cariostatic ﬂuoride to new-generation oral disease-
preventive agents, and to identify new biomarkers relevant to oral
diseases [52]. Microbial bioﬁlms in the oral cavity are involved in
the etiology of caries, periodontitis, and endodontic diseases [52].
Takenaka and his colleagues discussed the latest approaches to oral
bioﬁlms with a special focus on mature bioﬁlms [53]. Matrix-
targeting strategies seem a reasonable approach to the control of
mature oral bioﬁlms because antimicrobial penetration is retarded
by extracellular polymeric substances. Mechanical elimination is
still essential and remains the basic approach to the control of
mature oral bioﬁlms, whereas chemical treatment does not appear
to be effective in the absence of mechanical debridement [54].
The matrix-targeting strategy is therefore considered a novel
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elimination for the control of mature oral bioﬁlms.7. From oral sciences to health sciences—Promotion of oral
health sciences
Monosodium L-glutamate (MSG) produces a unique taste sensa-
tion termed ‘‘umami’’ and is widely used in various cuisines as a
ﬂavor enhancer. In addition, recent studies have suggested the
presence of receptors and transduction molecules for L-glutamate
(Glu) in the gut mucosa as well as in the oral cavity [55]. Torii
reviewed and summarized recent research articles documenting the
role of MSG in gut-brain communication and its place in a healthy
diet and lifestyle [56]. The gastric afferent vagal nerve, which
regulates autonomic reﬂexes, responds speciﬁcally to luminal sti-
mulation by Glu in the stomach [57,58]. The intragastric infusion of
MSG also activates several brain areas and is able to induce ﬂavor-
preference learning in rats [59,60]. These results suggest that Glu
signaling via the gustatory and visceral pathways plays important
roles in digestion, absorption, metabolism, and other physiological
functions by activating the brain.8. Studies in infection and immunity by the upcoming
generation
Toll-like receptors (TLRs) recognize molecular patterns on
various microbes and serve as innate immune sensors. After
cognate ligand recognition, TLRs activate signaling pathways to
induce innate immune defense mechanisms, which eliminate
pathogenic microbes, including periodontogenic bacteria, to a
certain extent. Inomata and Into reviewed their recent ﬁnding
of an autophagy-associated regulatory function of the nuclear dot
protein 52 (NDP52), an autophagy-associated protein, in Toll-like
receptor (TLR) signaling [61]. Recently, they demonstrated that
the signaling molecules Toll/interleukin-1 receptor homology
domain-containing adaptor-inducing interferon-b and tumor
necrosis factor receptor-associated factor 6 are selectively
degraded by autophagy after the activation of TLR signal trans-
duction, suggesting that NDP52 participates in such degradation
by negatively regulating TLR signaling [62]. P. gingivalis is con-
sidered the most important etiologic agent in chronic period-
ontitis and secretes several proteases that promote disease
progression by degrading host cells and proteins. Gingipains are
secretory endoproteases with trypsin-like activity produced by
P. gingivalis and are particularly important for both degradation
of host proteins and growth of P. gingivalis. Saiki and Konishi
introduced recent advances in the study of the secretion of
gingipains [63]. They identiﬁed 3 novel proteins, Sov (PG810–
PG809), PG27, and PG534, that are essential for the secretion and
activity of the gingipains [64,65]. They also showed that both Sov
and PG27 are essential for asaccharolytic growth of P. gingivalis.
Therefore, in addition to gingipains, which themselves are viru-
lence/proliferation factors, other factors participating in gingipain
secretion may also be important targets of new drugs against
periodontitis. Bacteria must adhere to and colonize the host
tissues in order to exert their pathogenicity. P. gingivalis, a
periodontal pathogen, primarily exploits FimA ﬁmbriae for adhe-
sion and colonization. FimA ﬁmbriae are polymers composed of
FimA protein encoded by the ﬁmA gene. The ﬁmA gene exists as a
single copy within the ﬁm gene cluster, which contains 7 genes:
ﬁmX, pgmA, and ﬁmABCDE. Nagano and his colleagues addressed
the roles of these genes in ﬁmbrial formation [66]. Elongation of
FimA ﬁmbriae is terminated by FimB, and the length of these
ﬁmbriae is determined by the ratio of the expression levels of theFimA and FimB proteins [67]. While the genes in the ﬁm cluster,
with the exception of ﬁmA, can potentially inﬂuence FimA protein
expression, they are not essential for the polymerization of FimA
proteins in the ﬁmbriae. Epstein-Barr virus (EBV) is a ubiquitous
human gamma herpes virus that causes several human diseases,
including infectious mononucleosis, autoimmune disorders, and a
number of malignancies. Imai and his colleagues reviewed the
molecular mechanisms involved in the maintenance of EBV
latency and its reactivation by periodontopathic bacteria and also
discussed possible mechanisms by which EBV reactivation may
facilitate the progression of periodontal disease in infected
individuals [68]. They focused on the intermicrobial interaction
between bacteria and viruses in the etiology of infectious disease
and found that the periodontal pathogen P. gingivalis could induce
EBV reactivation via chromatin modiﬁcation [69]. Their observa-
tions provide evidence for a possible intermicrobial interaction
between bacteria and EBV that may contribute to the pathogen-
esis of EBV-related diseases.9. Challenges for new horizons in bone research
Endochondral ossiﬁcation plays critical roles in skeletal growth,
tissue patterning, and craniofacial development. This unique and
complex biological event consists of multiple steps, including
condensation of mesenchymal stem cells (MSC), differentiation of
MSCs into chondrocytes, chondrocyte proliferation, hypertrophy,
and apoptosis, calciﬁcation and degradation of cartilage matrices,
and vascular invasion into cartilage tissues [70]. Nishimura and his
colleagues overviewed the signiﬁcance of several transcriptional
factors, such as Sox9, Runx2, and Osterix, in endochondral ossiﬁca-
tion [71]. Recently, they demonstrated the multi-functional role of
Sox9 and the critical importance of Runx2–Osterix linkage during
endochondral ossiﬁcation [72–74].10. Dynamism of the extracellular environment
The formation of dentin is a dynamic process that is triggered
and controlled by a functional network of matrix molecules and
diffusible growth factors. Heparan sulfate (HS) is ubiquitously
present on the cell surface and in the extracellular matrix and is
an essential regulator of cell signaling and development [75,76].
Yamashiro discussed the signiﬁcance of the sulfation of cell
surface HS in dentinogenesis [77]. 6-O-desulfation of extracellular
HSPGs is an important post-synthetic modiﬁcation that is critical
for the activation of Wnt signaling in odontoblast differentiation
and the subsequent production of the dentin matrix. Sulfatase
enzymes catalyze HS 6-O-desulfation on the odontoblast cell
surface, and this post-synthetic modiﬁcation of HSPG sulfation
induces the Wnt10a-mediated activation of odontoblast differ-
entiation [78].
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